Gabapentin Tablet, Film Coated
FDA Label NDC 65841-705

2 label sections · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Gabapentin (NDC 65841-705). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding spl medguide, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Spl Medguide

Manufactured by:

Cadila Heathcare Ltd.

India

Package Label.Principal Display Panel

NDC 65841-705-01 in bottle of 100 tablets

Gabapentin Tablets USP, 600 mg

Rx only

100 tablets

Gabapentin Tablets (62f7b0d7 C088 42f8 8e1f 7dea5f736fb9 01)

Gabapentin Tablets (62f7b0d7 C088 42f8 8e1f 7dea5f736fb9 01)

NDC 65841-706-01 in bottle of 100 tablets

Gabapentin Tablets USP, 800 mg

Rx only

100 tablets

Gabapentin Tablets (62f7b0d7 C088 42f8 8e1f 7dea5f736fb9 02)

Gabapentin Tablets (62f7b0d7 C088 42f8 8e1f 7dea5f736fb9 02)

* Please review the disclaimer below.